AI Article Synopsis
- Malignant diseases and their treatments impose significant burdens on patients, which can be immediate or manifest over time, affecting their overall quality of life.
- The toxic effects of cancer treatments often lead to both physical and psychological challenges, creating a wide range of issues for survivors.
- Session III of the Colloquium on Cardio-Oncology addresses these concerns from both healthcare professionals' and patients' perspectives, highlighting the trade-offs between increased survival and the long-term impacts of treatment.
Article Abstract
Malignant disease and its treatment carry huge burdens for patients. Some are immediate, in that the disease itself presents as a life threatening event, or the treatment may result in immediate and devastating toxicity. More often the treatment of cancer is associated with more subtle or late events, yet these may impact the quality of life for cancer survivors in a variety of ways. In addition to the physical sequelae of cancer or its treatment, cancer survivors often experience consequences in the form of social or mental incapacity. Session III of this Colloquium on Cardio-Oncology focuses on some of these concerns, both from the perspective of health care providers who strive to minimize the burdens, but also from the viewpoint of the patient him or herself who must deal with the price that must often be paid for increased survival or cure.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1053/j.seminoncol.2019.01.007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Caregiving responsibility and psychological distress among community-dwelling cancer survivors in the United States.
Support Care Cancer
January 2025
Department of Communication and Film, the University of Memphis, Memphis, TN, USA.
Purpose: There are over 18 million cancer survivors in the U.S., with a projected increase of 24.
View Article and Find Full Text PDFBrief, Family-Centered, Videoconference-Based Behavioral Insomnia Program in Elementary School-Aged Pediatric Cancer Survivors: A Proof-of-Concept Study.
Pediatr Blood Cancer
January 2025
Perini Family Survivors' Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Pediatric cancer survivors are at heightened risk for insomnia. Though behavioral interventions are the recommended approach, there are not enough trained clinicians. No known published trials have been conducted among school-aged survivors, despite them having unique age-related sleep issues.
View Article and Find Full Text PDFParental Acceptance of Human Papillomavirus Vaccination Among Females Treated for Childhood Cancer and/or With Hematopoietic Stem Cell Transplantation: A Cross-Sectional Study.
Pediatr Blood Cancer
January 2025
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Background: Survivors of childhood cancer (CCS) and hematopoietic stem cell transplantation (HSCT) recipients are at increased risk of human papillomavirus (HPV)-associated malignancies. Although HPV vaccination is recommended for these groups, parental acceptance remains uncertain.
Procedure: We recruited caregivers of female CCS/HSCT aged ≥9 years from the Shanghai Children's Medical Center (SCMC) vaccination clinic.
Metabolic syndrome is associated with breast cancer mortality: A systematic review and meta-analysis.
J Intern Med
January 2025
Department of Oncology, Aarhus University Hospital/Aarhus University, Aarhus, Denmark.
Background: This systematic review and meta-analysis assesses the association between metabolic syndrome and breast cancer (BC) outcomes in BC survivors.
Methods: Systematic searches were carried out in PubMed and Embase using variations of the search terms: breast neoplasms (population), metabolic syndrome (exposure), and survival (outcome). Metabolic syndrome was characterized according to the American Heart Association, which includes the presence of three out of five abnormal findings among the risk factors: high blood pressure, high triglycerides, low high-density lipoprotein, high fasting glucose, and central obesity.
A national estimate of mental disorders and mortality outcomes in cancer survivors.
Cancer
January 2025
Department of Preventive Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea.
Background: This study evaluated the prevalence of various mental disorders and their influence on mortality outcomes in individuals with cancer.
Methods: The authors' institutional database included patients with cancer diagnosed between 2011 and 2015 who had mental disorders and death information up to 2021. Mental disorders included nonaffective psychotic disorders, affective psychotic disorders, anxiety-related and stress-related disorders, alcohol or drug misuse, and mood disorders without psychotic symptoms.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!